Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Healthy Returns: Eli Lilly’s chief scientific officer breaks down the latest obesity pill data
Tags Eli Lilly and Co Social issues Healthy Returns
From CNBC.com News
Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval
Tags Novo Nordisk A/S Breaking News: Business Business
From CNBC.com News
A world on weight loss drugs: How GLP-1s are reshaping the economy
Tags Biotech and Pharmaceuticals Roche Holding AG AstraZeneca PLC
From CNBC.com News
Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investors
Tags Business News Pfizer Inc Business
From CNBC.com News
FDA approves first-ever glucose monitoring system for weight loss from Signos
Tags Companies Health & Science Health care industry
From CNBC.com News
Viking Therapeutics shares fall more than 30% on disappointing obesity pill trial data
Tags Pfizer Inc Business News Novo Nordisk A/S
From CNBC.com News
Home Depot disappoints, Novo Nordisk's GLP-1 updates, an AI warning and more in Morning Squawk
Tags TJX Companies Inc Personnel Investment strategy
From CNBC.com News
Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients
Tags Pharmaceuticals US: News Eli Lilly and Co
From CNBC.com News
5 things to know before the Thursday open: Chip tariffs | Cook's White House visit | Wall Street's fashionista
Tags Economy 5 Things to Know Eli Lilly and Co
From CNBC.com News
Eli Lilly's obesity pill led to more than 12% weight loss in closely watched late-stage trial, paving way for approval
Tags Business Biotechnology Novo Nordisk A/S
From CNBC.com News
Wegovy maker Novo Nordisk's sales hike in second quarter
Tags Pharmaceuticals Europe News Europe Markets
From CNBC.com News
Healthy Returns: Medicare, Medicaid will reportedly pilot covering obesity drugs – a potential win for drugmakers
Tags Eli Lilly and Co CVS Health Corp UnitedHealth Group Inc
From CNBC.com News
Hims & Hers stock falls 10% on revenue miss
Tags Breaking News: Technology Internet Business News
From CNBC.com News
Cramer's week ahead: Earnings from Palantir, Berkshire Hathaway, Disney and McDonald's
Tags Business Pfizer Inc Pinterest Inc
From CNBC.com News
Trump's drug price ultimatum sets pharma firms scrambling
Tags Eli Lilly and Co Gilead Sciences Inc Pharmaceuticals
From CNBC.com News
Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity
Tags Biotech and Pharmaceuticals Breaking News: Business Novo Nordisk A/S
From CNBC.com News
Trump's pharmaceutical tariffs could affect some drugmakers more than others
Tags Pfizer Inc Business Merck & Co Inc
From CNBC.com News
Shares of Novo Nordisk plunge 15% after Wegovy-maker cuts full-year guidance
Tags Earnings Breaking News: Europe Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Researchers move closer to a universal cancer vaccine
Tags Moderna Inc Merck & Co Inc Novo Nordisk A/S
From CNBC.com News
Europe’s most valuable firm SAP flags U.S. trade slowdown but says Japan deal gives 'hope'
Tags Markets Earnings outlook Breaking News: Economy
From CNBC.com News
Weight loss drugs could be a gamechanger for women with a common hormonal disorder
Tags Biotech and Pharmaceuticals Business News Biotechnology
From CNBC.com News
Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound
Tags Biotech and Pharmaceuticals Social issues Eli Lilly and Co
From CNBC.com News
Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses
Tags Novo Nordisk A/S Business Biotechnology
From CNBC.com News
Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than others
Tags Pfizer Inc Vertex Pharmaceuticals Inc Novo Nordisk A/S
From CNBC.com News
Healthy Returns: New weight loss drug data show Eli Lilly is gaining ground
Tags LILLY DRN Biotech and Pharmaceuticals Healthy Returns
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Tesla Inc Business News Politics
From CNBC.com News
Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%
Tags Hims & Hers Health Inc Health & Science Companies
From CNBC.com News
Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition
Tags Health care industry Health & Science Novo Nordisk A/S
From CNBC.com News
Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs
Tags Health care industry Health & Science CVS Health Corp
From CNBC.com News
Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly
Tags Pharmaceuticals US: News Health & Science
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.